Skip to Content

Fenofibric acid Pregnancy and Breastfeeding Warnings

Fenofibric acid is also known as: Fibricor, Trilipix

Medically reviewed on December 7, 2017

Fenofibric acid Pregnancy Warnings

Animal studies have failed to reveal evidence of adverse developmental effects. Maternal toxicity and aborted litters have occurred at higher doses. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

US FDA pregnancy category: C

See references

Fenofibric acid Breastfeeding Warnings

Use is contraindicated.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Fibricor (fenofibric acid)." AR Scientific Inc, Philadelphia, PA.
  2. "Product Information. Trilipix (fenofibric acid)." Abbott Pharmaceutical, Abbott Park, IL.

References for breastfeeding information

  1. "Product Information. Fibricor (fenofibric acid)." AR Scientific Inc, Philadelphia, PA.
  2. "Product Information. Trilipix (fenofibric acid)." Abbott Pharmaceutical, Abbott Park, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide